GSK

News

Bone marrow aspirate showing the histologic correlate of multiple myeloma under the microscope, H&E stain

GSK hails survival data with revived myeloma drug Blenrep

GSK's drive to resurrect its multiple myeloma therapy Blenrep has continued with new data from the DREAMM-7 trial showing an increase in overall survival (OS) with the drug had reached stat

News

Alarm bell rings for GSK as US policy dents RSV jab sales

Sales of GSK's respiratory syncytial virus (RSV) vaccine Arexvy slumped 72% in the third quarter of this year, as narrower recommendations on its use in the US started to have an effect.

News

GSK plans $800m US manufacturing investment

GSK has made another investment in its manufacturing network, setting aside $800 million to build two plants at its Marietta site in the US.

News

FDA set to decide on GSK's gepotidacin antibiotic in March

The FDA has started a priority review of GSK's gepotidacin, which could become the first in a new class of oral antibiotics for uncomplicated urinary tract infections (uUTIs) in over 20 yea

News

GSK turns its guns on Moderna in mRNA jab patent dispute

GSK has filed a pair of lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and respiratory syncytial virus (RSV).

News

GSK asthma hope depemokimab works in second indication

GSK's experimental IL-5 inhibitor depemokimab has shown its potential in a pair of phase 3 trials in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).

GSK hails survival data with revived myeloma drug Blenrep

Alarm bell rings for GSK as US policy dents RSV jab sales

GSK plans $800m US manufacturing investment

FDA set to decide on GSK's gepotidacin antibiotic in March

GSK turns its guns on Moderna in mRNA jab patent dispute

GSK asthma hope depemokimab works in second indication

Infex chases after Insmed with bronchiectasis trial win

Discover a new era of healthcare panel engagement: Grounded ...

GSK

Editor's Picks